Drug Development in NMIBC from Scientific, Regulatory, Clinician, and Patient Perspectives (2021)

AUA
America/New York GMT -4 summer

Description

Sarah Psutka

Opening Remarks, Recap from Previous Day, and Goal Setting, SESSION TWO: Clinical Dilemmas in Management of NMIBC, Trial Design Considerations for Intermediate Risk NMIBC, The Natural History of High Risk NMIBC: Novel Therapies versus Cystectomy, Sequential Therapy in BCG Unresponsive Disease, Discussion, Q&A, Keynote: The Science of Combination Therapy, Keynote: Racial Disparities in Cancer Clinical Trials, Closing Remarks

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Matthew Galsky, Yair Lotan, Trinity Bivalacqua, Angela Smith, Sima Porten, Adam Palmer, Otis Webb Brawley

 
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2021 "25 years inspiring technology"